{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:48:57Z","timestamp":1768074537264,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.vaccine.2010.12.063","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T09:20:34Z","timestamp":1293787234000},"page":"6817-6822","source":"Crossref","is-referenced-by-count":48,"title":["A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients"],"prefix":"10.1016","volume":"29","author":[{"given":"Caroline","family":"Staff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Mozaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Kristian","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Wahren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Liljefors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2010.12.063_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"issue":"January (9454)","key":"10.1016\/j.vaccine.2010.12.063_bib0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(05)17706-X","article-title":"Colorectal cancer","volume":"365","author":"Weitz","year":"2005","journal-title":"Lancet"},{"issue":"May (7)","key":"10.1016\/j.vaccine.2010.12.063_bib0015","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0959-8049(02)00062-X","article-title":"Systemic treatment of colorectal cancer","volume":"38","author":"Tebbutt","year":"2002","journal-title":"Eur J Cancer"},{"issue":"October (9)","key":"10.1016\/j.vaccine.2010.12.063_bib0020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1634\/theoncologist.11-9-973","article-title":"New approaches to the adjuvant therapy of colon cancer","volume":"11","author":"Benson","year":"2006","journal-title":"Oncologist"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2010.12.063_bib0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-122-5-199503010-00001","article-title":"Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report","volume":"122","author":"Moertel","year":"1995","journal-title":"Ann Intern Med"},{"issue":"October (9290)","key":"10.1016\/j.vaccine.2010.12.063_bib0030","first-page":"1291","article-title":"Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials","volume":"358","year":"2001","journal-title":"Lancet"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2010.12.063_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues","volume":"9","author":"Hammarstrom","year":"1999","journal-title":"Semin Cancer Biol"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2010.12.063_bib0040","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.2002.08.017","article-title":"Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review","volume":"20","author":"Berinstein","year":"2002","journal-title":"J Clin Oncol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2010.12.063_bib0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/14760584.4.3.329","article-title":"Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials","volume":"4","author":"Mosolits","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2010.12.063_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s002620050513","article-title":"Pharmacological administration of granulocyte\/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen","volume":"47","author":"Samanci","year":"1998","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2010.12.063_bib0175","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/174378","article-title":"DNA vaccines: developing new strategies against cancer","volume":"2010","author":"Fioretti","year":"2010","journal-title":"J Biomed Biotechnol."},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.12.063_bib0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molmed.2006.03.007","article-title":"Gene-based vaccines: recent technical and clinical advances","volume":"12","author":"Ulmer","year":"2006","journal-title":"Trends Mol Med"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2010.12.063_bib0065","doi-asserted-by":"crossref","first-page":"B24","DOI":"10.1016\/j.vaccine.2007.05.030","article-title":"Plasmid DNA and viral vector-based vaccines for the treatment of cancer","volume":"25","author":"Anderson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.063_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0065-2660(05)54011-2","article-title":"DNA vaccine","volume":"54","author":"Cui","year":"2005","journal-title":"Adv Genet"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.063_bib0075","first-page":"34","article-title":"Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine","volume":"6","author":"Conry","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.12.063_bib0080","first-page":"2782","article-title":"Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients","volume":"8","author":"Conry","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.12.063_bib0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.cgt.7700574","article-title":"Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system","volume":"10","author":"Lund","year":"2003","journal-title":"Cancer Gene Ther"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2010.12.063_bib0090","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","article-title":"Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide","volume":"105","author":"Lutsiak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2010.12.063_bib0095","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2741\/3338","article-title":"Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines","volume":"14","author":"Ruter","year":"2009","journal-title":"Front Biosci"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2010.12.063_bib0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-3083.2007.01945.x","article-title":"Pre-clinical evaluation of a CEA DNA prime\/protein boost vaccination strategy against colorectal cancer","volume":"66","author":"Hallermalm","year":"2007","journal-title":"Scand J Immunol"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2010.12.063_bib0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(02)00159-2","article-title":"Immunology and immunotherapy of colorectal cancer","volume":"46","author":"Dalerba","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2010.12.063_bib0110","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1158\/1078-0432.CCR-03-0706","article-title":"Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte\/macrophage colony-stimulating factor","volume":"10","author":"Ullenhag","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2010.12.063_bib0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00063030-199708040-00004","article-title":"DNA vaccines: a review of developments","volume":"8","author":"Webster","year":"1997","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2010.12.063_bib0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2660(05)55002-8","article-title":"Human clinical trials of plasmid DNA vaccines","volume":"55","author":"Liu","year":"2005","journal-title":"Adv Genet"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2010.12.063_bib0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/515613","article-title":"First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response","volume":"178","author":"MacGregor","year":"1998","journal-title":"J Infect Dis"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2010.12.063_bib0130","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2005.10.206","article-title":"Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas","volume":"23","author":"Marshall","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vaccine.2010.12.063_bib0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization*","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.12.063_bib0140","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ymthe.2005.06.473","article-title":"Multigene\/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery","volume":"12","author":"Brave","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.12.063_bib0145","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1100\/tsw.2007.138","article-title":"Intracellular targeting of CEA results in Th1-type antibody responses following intradermal genetic vaccination by a needle-free jet injection device","volume":"7","author":"Johansson","year":"2007","journal-title":"Sci World J"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.12.063_bib0150","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd2076","article-title":"Current status and future prospects of needle-free liquid jet injectors","volume":"5","author":"Mitragotri","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2010.12.063_bib0155","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/toxsci\/kfj169","article-title":"Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts","volume":"91","author":"Sheets","year":"2006","journal-title":"Toxicol Sci"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2010.12.063_bib0160","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/592507","article-title":"Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara","volume":"198","author":"Sandstrom","year":"2008","journal-title":"J Infect Dis"},{"issue":"4\u20136","key":"10.1016\/j.vaccine.2010.12.063_bib0165","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000053993","article-title":"Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice","volume":"43","author":"Ledwith","year":"2000","journal-title":"Intervirology"},{"issue":"June (28)","key":"10.1016\/j.vaccine.2010.12.063_bib0170","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.vaccine.2009.04.013","article-title":"Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen","volume":"27","author":"Brave","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T12:47:42Z","timestamp":1559911662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10018360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":34,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0264410X10018360"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}